Mapping large numbers of results may take a few moments.
Search Results
Showing 1 - 46 of 46 results found.
| Company | Activity | Company Description | Location | |
|---|---|---|---|---|
 |
Company Achelios Therapeutics Inc. | Activity: Research and Development | Company Description Achelios Therapeutics develops novel topical therapies for inflammatory pain, such as joint, muscle temporomandibular and migraine pain. | Location Durham |
| |
Company Aestas Pharma Inc. | Activity: Research and Development | Company Description Aestas Pharma develops novel diagnostic imaging and disease-modifying therapeutic agents to enable the early treatment and reversal of Alzheimer’s and Parkinson’s disease when clinical signs are not yet pronounced. | Location Durham |
| |
Company AimMax Therapeutics Inc. | Activity: Research and Development | Company Description AimMax Therapeutics researches and develops biopharmaceuticals for the treatment of infection, inflammation and pain through in-licensing or co-development with strategic partners. | Location Durham |
| |
Company Amalgent Therapeutics Inc. | Activity: Research and Development | Company Description Amalgent is a clinical-stage company developing novel pain management therapeutics for the treatment of pain without addiction. | Location Greenville |
| |
Company Aniluxx Biotechnology Inc. | Activity: Research and Development | Company Description Aniluxx Biotechnology translates human therapies to dogs, cats and horses to treat itching and pain. | Location Chapel Hill |
| |
Company Balanced Pharma Inc. | Activity: Research and Development | Company Description Balanced Pharma is developing pH-balanced (buffered) injectable anesthetic drugs with enhanced usability qualities for use in dental and dermatological surgery. | Location Cornelius |
| |
Company Dechra Pharmaceuticals | Activity: Research and Development | Company Description Dechra Pharmaceuticals develops veterinary pharmaceuticals with a focus on major companion animal categories. | Location Greensboro |
| |
Company GSK (Durham) | Activity: Research and Development | Company Description GSK develops and manufactures vaccines and medicines, with a focus on science related to the immune system, human genetics and advanced technologies. | Location Durham |
| |
Company Interventional AnalgesiX Inc. | Activity: Research and Development | Company Description Interventional AnalgesiX is developing non-addictive analgesics for chronic pain. | Location Durham |
| |
Company Isosceles Pharmaceuticals Inc. | Activity: Research and Development | Company Description Isosceles Pharmaceuticals is a specialty pharmaceutical company developing novel therapeutics for pain indications. | Location Wilmington |
| |
Company Kowa Research Institute Inc. | Activity: Research and Development | Company Description Kowa Research Institute, a division of Kowa Company Ltd., develops therapeutic drugs for the treatment of cardio-metabolic diseases such as diabetes and atherosclerosis, pain and sensory organ disorders. | Location Morrisville |
| |
Company LVM Biosciences Inc. | Activity: Research and Development | Company Description LVM Biosciences develops therapeutics for epilepsy, stroke, anxiety, migraine, and pain. | Location Chapel Hill |
| |
Company Mallinckrodt Pharmaceuticals | Activity: Production and Manufacturing | Company Description Mallinckrodt manufactures acetaminophen, the active ingredient in Tylenol, at its pharmaceutical facility in Raleigh. | Location Raleigh |
| |
Company Mind Medicine Inc. | Activity: Research and Development | Company Description Mind Medicine is a clinical-stage biopharmaceutical company developing products using the therapeutic potential of psychedelics to treat brain health disorders, with a focus on psychiatry, addiction, pain and neurology. | Location Durham |
| |
Company NuBioPharma LLC | Activity: Research and Development | Company Description NuBioPharma develops and formulates novel liquid medications with child-friendly flavors for debilitating orphan diseases. Therapeutic areas include gout, pulmonary arterial hypertension and thrombocythemia. | Location Sanford |
| |
Company Nufabrx | Activity: Production and Manufacturing | Company Description Nufabrx develops wearable technology that embeds therapeutic active ingredients into textiles for repeatable transdermal delivery to treat pain relief. | Location Conover |
| |
Company Ocaro Pharmaceuticals | Activity: Research and Development | Company Description Ocaro Pharmaceuticals develops opioid-sparing pain medications. | Location Greensboro |
| |
Company Olfax LLC | Activity: Research and Development | Company Description Olfax Medical is developing nasally administered therapeutics to help patients avoid the harmful and addictive side effects of systemic pharmaceuticals. | Location Asheville |
| |
Company Pisgah Labs Inc. | Activity: Production and Manufacturing | Company Description Pisgah Labs manufactures active pharmaceutical ingredients for pain medicines and the treatment of disorders and diseases, such as Alzheimer's and fibromyalgia, on a contract basis. Pisgah Labs' cGMP facility includes an aseptic manufacturing suite. | Location Pisgah Forest |
| |
Company Purdue Pharmaceuticals LP | Activity: Production and Manufacturing | Company Description Purdue Pharma develops and provides prescription medicines for the treatment of pain. The Wilson plant manufactures, packages and distributes oral solid-dose tablets and is the company's distribution center for prescription products. | Location Wilson |
| |
Company Rilento Pharma LLC | Activity: Research and Development | Company Description Rilento Pharma is an early stage drug delivery company developing non-addictive oral surgery pain management technologies that are synchronized with the biologic process of wound healing. | Location Raleigh |
| |
Company Satsuma Pharmaceuticals Inc. | Activity: Research and Development | Company Description Satsuma Pharmaceuticals is developing best-in-class intranasal drug products to address the significant unmet medical needs of acute migraine sufferers. | Location Durham |
| |
Company Symberix Inc. | Activity: Research and Development | Company Description Symberix is developing microbiome-targeted, small-molecule drugs to treat serious lower gastrointestinal (GI) diseases as well as mitigate the lower GI side effects associated with various cancer, pain and immunosuppressive therapies. | Location Durham |